S

Soleno Therapeutics
D

SLNO

39.530
USD
2.57
(6.95%)
مغلق
حجم التداول
132,310
الربح لكل سهم
4
العائد الربحي
-
P/E
101
حجم السوق
2,123,157,288
أصول ذات صلة المقالات

العنوان: Soleno Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue. The company's reporting segment focused on the development and commercialization of its sole therapeutic product, VYKAT XR.